Verastem (VSTM) Share-based Compensation (2011 - 2026)
Verastem's (VSTM) quarterly Share-based Compensation came in at $2.5 million in Q1 2026, up 40.66% year-on-year from $1.8 million in Q1 2025, and up 24.2% quarter-over-quarter from $2.0 million in Q4 2025.
Verastem (VSTM) Share-based Compensation (2011 - 2026) Analysis & Trends
Verastem's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 40.66% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $10.1 million, a 683.53% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 851.82% from the prior year.
- Share-based Compensation climbed to $2.5 million in Q1 2026 per VSTM's latest filing, from $2.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.4 million in Q2 2025 and bottomed at -$4.3 million in Q4 2024.
- The 5-year median for Share-based Compensation is $1.6 million (2022), against an average of $1.5 million.
- Across the five-year window, Share-based Compensation plunged 371.28% in 2024 and jumped 146.71% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $1.3 million in 2022, then advanced by 24.16% to $1.6 million in 2023, then plunged by 371.28% to -$4.3 million in 2024, then soared by 146.71% to $2.0 million in 2025, then climbed by 24.2% to $2.5 million in 2026.
- Per Business Quant, the three latest VSTM Share-based Compensation figures stand at $2.5 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.52 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | -4.34 Mn |
| Dec 31, 2024 | -4.34 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |